Bluefin Capital Management’s Aceragen Inc ACGN Stock Holding History

Bluefin Capital Management’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,317	Closed	-$329K	–	521
2018 Q1	$329K	Buy	+1,317	New	+$361K	0.02%	237

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bluefin Capital Management's ACGN Position: Q2 2018 in Review

Bluefin Capital Management sold out of Aceragen Inc (ACGN) in Q2 2018, closing a stake of 1,317 shares — an estimated $329K sold.

Bluefin Capital Management first reported a position in ACGN in Q1 2018 and held it in 1 quarter. The position peaked at $329K in Q1 2018. 93 funds tracked by Wall St. Rank hold ACGN as of Q2 2018.

Bluefin Capital Management reported no remaining Aceragen Inc position as of Q2 2018 after selling out during the quarter.
Bluefin Capital Management sold 1,317 Aceragen Inc shares in Q2 2018, an estimated $329K.
Bluefin Capital Management first reported a position in Aceragen Inc in Q1 2018 and held it in 1 quarter.
Bluefin Capital Management's Aceragen Inc position peaked at $329K in Q1 2018.
93 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2018.

Based on Bluefin Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.